NEW YORK, April 8, 2021 /PRNewswire/ -- CBAM, an alternative investment management firm, today announced the closing of its 14th US collateralized loan obligation (CLO), CBAM 2021-14, totaling $407 million, with J.P. Morgan acting as lead arranger. This brings CBAM's total CLO issuance to nearly $12.4 billion since the closing of its first CLO in June 2017.
As of February 28, 2021, CBAM's AUM stood at $14.3 billion across multiple credit vehicles and separate accounts.
About CBAM CBAM Partners, LLC, an Eldridge business, is an investment management firm and SEC-registered investment adviser founded in 2016 by Don Young, Mike Damaso, and Jay Garrett, headquartered in New York. With $14.3 billion of AUM, CBAM specializes in opportunities across the credit spectrum for institutional clients through separately managed accounts, CLOs, and private funds. To learn more about CBAM please visit www.cbam.com
Tuya Inc. ("Tuya" or the "Company") , a global leading cloud platform service provider, today announced its unaudited financial results for the first quarter ended March 31, 2024.
First Quarter 2024 Financial Highlights
Total revenue was US61.7...
Montana Technologies Corporation ("Montana Technologies"), the developer of AirJoule®, a transformational atmospheric thermal energy and water harvesting technology, today announced its first quarter results....
Brown Gibbons Lang & Company (BGL) is pleased to announce the recapitalization of Musser Biomass and Wood Products ("Musser" or the "Company"), a leading producer of premium ESG-certified reclaimed biomass wood fiber, by the Watermill Group. BGL's...
Today Transamerica announced a new collaboration with FT Indexing Solutions LLC ("First Trust") that adds the First Trust Equity Edge Indextm to the popular and innovative Transamerica Structured Index Advantage® Annuity....
WildFire Energy I LLC ("WildFire"), today announced that it has entered into a definitive agreement for the acquisition of approximately 237,000 net acres and interests in 465 wells in the East Texas Eagle Ford from Apache Corporation and...
Taro Pharmaceutical Industries Ltd. ("Taro" or the "Company") today provided unaudited financial results for the quarter and year ended March 31, 2024.
Quarter ended March 31, 2024 Highlights ? compared to March 31, 2023
Net sales of $164.9...
